Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (126)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Kumar-Singh, R.
Right arrow Articles by Chamberlain, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kumar-Singh, R.
Right arrow Articles by Chamberlain, J. S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, Vol 5, 913-921, Copyright © 1996 by Oxford University Press

ARTICLES

Encapsidated adenovirus minichromosomes allow delivery and expression of a 14 kb dystrophin cDNA to muscle cells

R Kumar-Singh and JS Chamberlain
Department of Human Genetics, University of Michigan Medical School, Ann Arbor 48109-0618, USA.

Adenovirus-mediated gene transfer to muscle is a promising technology for gene therapy of Duchenne muscular dystrophy (DMD). However, currently available recombinant adenovirus vectors have several limitations, including a limited cloning capacity of approximately 8.5 kb, and the induction of a host immune response that leads to transient gene expression of 3-4 weeks in immunocompetent animals. Gene therapy for DMD could benefit from the development of adenoviral vectors with an increased cloning capacity to accommodate a full-length (approximately 14 kb) dystrophin cDNA. This increased capacity should also accommodate gene regulatory elements to achieve expression of transduced genes in a tissue-specific manner. Additional vector modifications that eliminate adenoviral genes, expression of which is associated with development of a host immune response, might greatly increase long-term expression of virally delivered genes in vivo. We have constructed encapsidated adenovirus minichromosomes theoretically capable of delivering up to 35 kb of non-viral exogenous DNA. These minichromosomes are derived from bacterial plasmids containing two fused inverted adenovirus origins of replication embedded in a circular genome, the adenovirus packaging signals, a beta-galactosidase reporter gene and a full-length dystrophin cDNA regulated by a muscle-specific enhancer/promoter. The encapsidated minichromosomes are propagated in vitro by trans-complementation with a replication-defective (E1 + E3 deleted) helper virus. We show that the minichromosomes can be propagated to high titer (> 10(8)/ml) and purified on CsCl gradients due to their buoyancy difference relative to helper virus. These vectors are able to transduce myogenic cell cultures and express dystrophin in myotubes. These results suggest that encapsidated adenovirus minichromosomes may be useful for gene transfer to muscle and other tissues.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Physiol. Rev.Home page
J. Davis, M. V. Westfall, D. Townsend, M. Blankinship, T. J. Herron, G. Guerrero-Serna, W. Wang, E. Devaney, and J. M. Metzger
Designing Heart Performance by Gene Transfer
Physiol Rev, October 1, 2008; 88(4): 1567 - 1651.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. R. Witting, M. Brown, R. Saxena, S. Nabinger, and N. Morral
Helper-dependent Adenovirus-mediated Short Hairpin RNA Expression in the Liver Activates the Interferon Response
J. Biol. Chem., January 25, 2008; 283(4): 2120 - 2128.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
M. A. F. V. Goncalves, G. P. van Nierop, M. R. Tijssen, P. Lefesvre, S. Knaan-Shanzer, I. van der Velde, D. W. van Bekkum, D. Valerio, and A. A. F. de Vries
Transfer of the Full-Length Dystrophin-Coding Sequence into Muscle Cells by a Dual High-Capacity Hybrid Viral Vector with Site-Specific Integration Ability
J. Virol., March 1, 2005; 79(5): 3146 - 3162.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
F. Sharif, K. Daly, J. Crowley, and T. O'Brien
Current status of catheter- and stent-based gene therapy
Cardiovasc Res, November 1, 2004; 64(2): 208 - 216.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
R. Gilbert, R. W. R. Dudley, A.-B. Liu, B. J. Petrof, J. Nalbantoglu, and G. Karpati
Prolonged dystrophin expression and functional correction of mdx mouse muscle following gene transfer with a helper-dependent (gutted) adenovirus-encoding murine dystrophin
Hum. Mol. Genet., June 1, 2003; 12(11): 1287 - 1299.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
J. S. Chamberlain
Gene therapy of muscular dystrophy
Hum. Mol. Genet., October 1, 2002; 11(20): 2355 - 2362.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
C. DelloRusso, J. M. Scott, D. Hartigan-O'Connor, G. Salvatori, C. Barjot, A. S. Robinson, R. W. Crawford, S. V. Brooks, and J. S. Chamberlain
Functional correction of adult mdx mouse muscle using gutted adenoviral vectors expressing full-length dystrophin
PNAS, October 1, 2002; 99(20): 12979 - 12984.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
W. Zhang, J. A. Low, J. B. Christensen, and M. J. Imperiale
Role for the Adenovirus IVa2 Protein in Packaging of Viral DNA
J. Virol., November 1, 2001; 75(21): 10446 - 10454.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
I.-H. Kim, A. Jozkowicz, P. A. Piedra, K. Oka, and L. Chan
Lifetime correction of genetic deficiency in mice with a single injection of helper-dependent adenoviral vector
PNAS, October 25, 2001; (2001) 241506298.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
M. Hillgenberg, H. Tonnies, and M. Strauss
Chromosomal Integration Pattern of a Helper-Dependent Minimal Adenovirus Vector with a Selectable Marker Inserted into a 27.4-Kilobase Genomic Stuffer
J. Virol., October 15, 2001; 75(20): 9896 - 9908.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
K. A. High
Gene Transfer as an Approach to Treating Hemophilia
Circ. Res., February 2, 2001; 88(2): 137 - 144.
[Abstract] [Full Text] [PDF]

Home page
 J. Gen. Virol.Home page
W. C. Russell
Update on adenovirus and its vectors
J. Gen. Virol., November 1, 2000; 81(11): 2573 - 2604.
[Full Text]

Home page
 Hum Mol GenetHome page
A. Ahmad, M. Brinson, B.L. Hodges, J.S. Chamberlain, and A. Amalfitano
Mdx mice inducibly expressing dystrophin provide insights into the potential of gene therapy for Duchenne muscular dystrophy
Hum. Mol. Genet., October 1, 2000; 9(17): 2507 - 2515.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
V. Sandig, R. Youil, A. J. Bett, L. L. Franlin, M. Oshima, D. Maione, F. Wang, M. L. Metzker, R. Savino, and C. T. Caskey
Optimization of the helper-dependent adenovirus system for production and potency in vivo
PNAS, February 1, 2000; 97(3): 1002 - 1007.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
J. Kamholz, D. Menichella, A. Jani, J. Garbern, R. A. Lewis, K. M. Krajewski, J. Lilien, S. S. Scherer, and M. E. Shy
Charcot-Marie-Tooth disease type 1: Molecular pathogenesis to gene therapy
Brain, February 1, 2000; 123(2): 222 - 233.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
C. Balague, J. Zhou, Y. Dai, R. Alemany, S. F. Josephs, G. Andreason, M. Hariharan, E. Sethi, E. Prokopenko, H.-y. Jan, et al.
Sustained high-level expression of full-length human factor VIII and restoration of clotting activity in hemophilic mice using a minimal adenovirus vector
Blood, February 1, 2000; 95(3): 820 - 828.
[Abstract] [Full Text] [PDF]

Home page
 ASH Education BookHome page
U. Hedner, D. Ginsburg, J. M. Lusher, and K. A. High
Congenital Hemorrhagic Disorders: New Insights into the Pathophysiology and Treatment of Hemophilia
Hematology, January 1, 2000; 2000(1): 241 - 265.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
M. Sena-Esteves, Y. Saeki, S. M. Camp, E. A. Chiocca, and X. O. Breakefield
Single-Step Conversion of Cells to Retrovirus Vector Producers with Herpes Simplex Virus-Epstein-Barr Virus Hybrid Amplicons
J. Virol., December 1, 1999; 73(12): 10426 - 10439.
[Abstract] [Full Text]

Home page
 J. Virol.Home page
D. S. Steinwaerder, C. A. Carlson, and A. Lieber
Generation of Adenovirus Vectors Devoid of All Viral Genes by Recombination between Inverted Repeats
J. Virol., November 1, 1999; 73(11): 9303 - 9313.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
N. Morral, W. O'Neal, K. Rice, M. Leland, J. Kaplan, P. A. Piedra, H. Zhou, R. J. Parks, R. Velji, E. Aguilar-Cordova, et al.
Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons
PNAS, October 26, 1999; 96(22): 12816 - 12821.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
R. J. Parks, J. L. Bramson, Y. Wan, C. L. Addison, and F. L. Graham
Effects of Stuffer DNA on Transgene Expression from Helper-Dependent Adenovirus Vectors
J. Virol., October 1, 1999; 73(10): 8027 - 8034.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
D. Hartigan-O'Connor, A. Amalfitano, and J. S. Chamberlain
Improved Production of Gutted Adenovirus in Cells Expressing Adenovirus Preterminal Protein and DNA Polymerase
J. Virol., September 1, 1999; 73(9): 7835 - 7841.
[Abstract] [Full Text]

Home page
 J. Virol.Home page
A. Harui, S. Suzuki, S. Kochanek, and K. Mitani
Frequency and Stability of Chromosomal Integration of Adenovirus Vectors
J. Virol., July 1, 1999; 73(7): 6141 - 6146.
[Abstract] [Full Text]

Home page
 J. Neurophysiol.Home page
J. R. Holt, D. C. Johns, S. Wang, Z.-Y. Chen, R. J. Dunn, E. Marban, and D. P. Corey
Functional Expression of Exogenous Proteins in Mammalian Sensory Hair Cells Infected With Adenoviral Vectors
J Neurophysiol, April 1, 1999; 81(4): 1881 - 1888.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. Recchia, R. J. Parks, S. Lamartina, C. Toniatti, L. Pieroni, F. Palombo, G. Ciliberto, F. L. Graham, R. Cortese, N. La Monica, et al.
Site-specific integration mediated by a hybrid adenovirus/adeno-associated virus vector
PNAS, March 16, 1999; 96(6): 2615 - 2620.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
A.-I. Michou, H. Lehrmann, M. Saltik, and M. Cotten
Mutational Analysis of the Avian Adenovirus CELO, Which Provides a Basis for Gene Delivery Vectors
J. Virol., February 1, 1999; 73(2): 1399 - 1410.
[Abstract] [Full Text]

Home page
 JCBHome page
Y.-m. Chan, C. G. Bonnemann, H. G.W. Lidov, and L. M. Kunkel
Molecular Organization of Sarcoglycan Complex in Mouse Myotubes in Culture
J. Cell Biol., December 28, 1998; 143(7): 2033 - 2044.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
T. Kafri, D. Morgan, T. Krahl, N. Sarvetnick, L. Sherman, and I. Verma
Cellular immune response to adenoviral vector infected cells does not require de novo viral gene expression: Implications for gene therapy
PNAS, September 15, 1998; 95(19): 11377 - 11382.
[Abstract] [Full Text] [PDF]

Home page
 JCBHome page
Z. Qu, L. Balkir, J. C.T. van Deutekom, P. D. Robbins, R. Pruchnic, and J. Huard
Development of Approaches to Improve Cell Survival in Myoblast Transfer Therapy
J. Cell Biol., September 7, 1998; 142(5): 1257 - 1267.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. A. Morsy, M. Gu, S. Motzel, J. Zhao, J. Lin, Q. Su, H. Allen, L. Franlin, R. J. Parks, F. L. Graham, et al.
An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene
PNAS, July 7, 1998; 95(14): 7866 - 7871.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
A. Amalfitano, M. A. Hauser, H. Hu, D. Serra, C. R. Begy, and J. S. Chamberlain
Production and Characterization of Improved Adenovirus Vectors with the E1, E2b, and E3 Genes Deleted
J. Virol., February 1, 1998; 72(2): 926 - 933.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
H.-H. Chen, L. M. Mack, R. Kelly, M. Ontell, S. Kochanek, and P. R. Clemens
Persistence in muscle of an adenoviral vector that lacks all viral genes
PNAS, March 4, 1997; 94(5): 1645 - 1650.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
I.-H. Kim, A. Jozkowicz, P. A. Piedra, K. Oka, and L. Chan
Lifetime correction of genetic deficiency in mice with a single injection of helper-dependent adenoviral vector
PNAS, November 6, 2001; 98(23): 13282 - 13287.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.